98%
921
2 minutes
20
Skin may be affected by many disorders that can be treated by topical applications of drugs on the action site. With the advent of nanotechnologies, new efficient delivery systems have been developed. Particularly, lipid-based nanosystems such as liposomes, ethosomes, transferosomes, solid lipid nanoparticles, nanostructured lipid carriers, cubosomes, and monoolein aqueous dispersions have been proposed for cutaneous application, reaching in some cases the market or clinical trials. This review aims to provide an overview of the different lipid-based nanosystems, focusing on their use for topical application. Particularly, biocompatible nanosystems able to dissolve lipophilic compounds and to control the release of carried drug, possibly reducing side effects, are described. Notably, the rationale to topically administer antioxidant molecules by lipid nanocarriers is described. Indeed, the structural similarity between the nanosystem lipid matrix and the skin lipids allows the achievement of a transdermal effect. Surely, more research is required to better understand the mechanism of interaction between lipid-based nanosystems and skin. However, this attempt to summarize and highlight the possibilities offered by lipid-based nanosystems could help the scientific community to take advantage of the benefits derived from this kind of nanosystem.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348303 | PMC |
http://dx.doi.org/10.3390/ijms22158319 | DOI Listing |
Pharmaceutics
August 2025
Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee 441002, Maharashtra, India.
Sunscreen protects skin from harmful Ultra Violet (UV) rays, preventing skin diseases like cancer and premature aging. This review explores the role of nanotechnology in enhancing sunscreen formulations by incorporating green and sustainable ingredients. Nanoparticles such as titanium dioxide and zinc oxide effectively reflect UV rays, improving protection while minimizing white residue, thereby enhancing aesthetics, stability, and efficacy.
View Article and Find Full Text PDFAdv Mater
August 2025
Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, 50009, Spain.
Bacteria exhibit adaptive phenotypic traits that confer resistance to host defenses and antimicrobial therapies. In response to the global threat of antimicrobial resistance, bacteria-responsive nanostructured drug delivery systems have emerged as a promising alternative to conventional broad-spectrum antimicrobials. These systems release therapeutics selectively in response to bacterial presence or to their secreted enzymes, toxins, antigens, or extracellular biomarkers, enabling precise activation at infection sites while minimizing off-target effects.
View Article and Find Full Text PDFNeurotherapeutics
August 2025
Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China. Electronic address:
Alzheimer's disease (AD) presents significant therapeutic challenges due to its multifactorial pathology, the inefficacy of traditional single-target drugs, and the poor bioavailability and limited blood-brain barrier (BBB) penetration of promising multi-target phytochemicals like curcumin, resveratrol, and quercetin. This review systematically examines the rational design and recent advancements in engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in AD. Nanotechnology leverages lipid-based systems (liposomes, solid lipid nanoparticles), polymer-based carriers (PLGA nanoparticles), inorganic nanosystems (gold, selenium nanoparticles), and biologically-derived vehicles to significantly enhance phytochemical stability, targeting efficiency, and brain accumulation.
View Article and Find Full Text PDFPharmaceutics
July 2025
ChIP Chemistry Interdisciplinary Project Research Centre, School of Pharmacy, University of Camerino, Via Madonna delle Carceri, 62032 Camerino, MC, Italy.
Neuropathic pain is a significant global clinical issue that poses substantial challenges to both public health and the economy due to its complex underlying mechanisms. It has emerged as a serious health concern worldwide. Recent studies involving dorsal root ganglion (DRG) stimulation have provided strong evidence supporting its effectiveness in alleviating chronic pain and its potential for sustaining long-term pain relief.
View Article and Find Full Text PDFJ Zhejiang Univ Sci B
June 2025
M. Kandiah Faculty of M edicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Kajang, Selangor, Malaysia.
Epigallocatechin-3-gallate (EGCG), a bioactive polyphenol abundant in green tea, has garnered significant attention for its diverse therapeutic applications, ranging from antioxidant and anti-inflammatory effects to potential anticancer properties. Despite its immense promise, the practical utilization of EGCG in therapeutic settings as a medication has been hampered by inherent limitations of this drug, including poor bioavailability, instability, and rapid degradation. This review comprehensively explores the current challenges associated with the application of EGCG and evaluates the potential of nanoparticle-based formulations in addressing these limitations.
View Article and Find Full Text PDF